Pay in 4 interest-free payments of $5.49 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
This represents a potentially novel dual hormone therapy for diabetes management and highlights the potential of rectal delivery systems for therapeutic and diagnostic hormones and proteins
Renal tubule Cpt1a overexpression protects from kidney fibrosis by restoring mitochondrial homeostasis
DOI: 10.1016/j.peptides.2005.01.029 Clinical Development Afamelanotide and EPP Afamelanotide (MT-1), delivered as a subcutaneous slow-release implant, has been studied in multiple randomised controlled trials in patients with erythropoietic protoporphyria (EPP)
Crailsheim, K
US$ 25.35
US$ 28.23
US$ 20.28
US$ 27.87
US$ 24.26
US$ 25.40
US$ 22.10
US$ 21.14
US$ 24.05
